Christian LoBue1, Hannah Wadsworth1, Kristin Wilmoth1, Matthew Clem1, John Hart1,2,3, Kyle B Womack1,2,3, Nyaz Didehbani1,3, Laura H Lacritz1,2, Heidi C Rossetti1, C Munro Cullum1,2,4. 1. a Department of Psychiatry , University of Texas Southwestern Medical Center , Dallas , TX , USA. 2. b Department of Neurology and Neurotherapeutics , University of Texas Southwestern Medical Center , Dallas , TX , USA. 3. d Center for BrainHealth, School of Behavioral and Brain Sciences , University of Texas at Dallas , Dallas , TX , USA. 4. c Department of Neurological Surgery , University of Texas Southwestern Medical Center , Dallas , TX , USA.
Abstract
OBJECTIVE: This study examined whether a history of traumatic brain injury (TBI) is associated with earlier onset of Alzheimer disease (AD), independent of apolipoprotein ε4 status (Apoe4) and gender. METHOD: Participants with a clinical diagnosis of AD (n = 7625) were obtained from the National Alzheimer's Coordinating Center Uniform Data Set, and categorized based on self-reported lifetime TBI with loss of consciousness (LOC) (TBI+ vs. TBI-) and presence of Apoe4. ANCOVAs, controlling for gender, race, and education were used to examine the association between history of TBI, presence of Apoe4, and an interaction of both risk factors on estimated age of AD onset. RESULTS: Estimated AD onset differed by TBI history and Apoe4 independently (p's < .001). The TBI+ group had a mean age of onset 2.5 years earlier than the TBI- group. Likewise, Apoe4 carriers had a mean age of onset 2.3 years earlier than non-carriers. While the interaction was non-significant (p = .34), participants having both a history of TBI and Apoe4 had the earliest mean age of onset compared to those with a TBI history or Apoe4 alone (MDifference = 2.8 and 2.7 years, respectively). These results remained unchanged when stratified by gender. CONCLUSIONS: History of self-reported TBI can be associated with an earlier onset of AD-related cognitive decline, regardless of Apoe4 status and gender. TBI may be related to an underlying neurodegenerative process in AD, but the implications of age at time of injury, severity, and repetitive injuries remain unclear.
OBJECTIVE: This study examined whether a history of traumatic brain injury (TBI) is associated with earlier onset of Alzheimer disease (AD), independent of apolipoprotein ε4 status (Apoe4) and gender. METHOD:Participants with a clinical diagnosis of AD (n = 7625) were obtained from the National Alzheimer's Coordinating Center Uniform Data Set, and categorized based on self-reported lifetime TBI with loss of consciousness (LOC) (TBI+ vs. TBI-) and presence of Apoe4. ANCOVAs, controlling for gender, race, and education were used to examine the association between history of TBI, presence of Apoe4, and an interaction of both risk factors on estimated age of AD onset. RESULTS: Estimated AD onset differed by TBI history and Apoe4 independently (p's < .001). The TBI+ group had a mean age of onset 2.5 years earlier than the TBI- group. Likewise, Apoe4 carriers had a mean age of onset 2.3 years earlier than non-carriers. While the interaction was non-significant (p = .34), participants having both a history of TBI and Apoe4 had the earliest mean age of onset compared to those with a TBI history or Apoe4 alone (MDifference = 2.8 and 2.7 years, respectively). These results remained unchanged when stratified by gender. CONCLUSIONS: History of self-reported TBI can be associated with an earlier onset of AD-related cognitive decline, regardless of Apoe4 status and gender. TBI may be related to an underlying neurodegenerative process in AD, but the implications of age at time of injury, severity, and repetitive injuries remain unclear.
Entities:
Keywords:
Alzheimer’s disease (AD); National Alzheimer’s Coordinating Center (NACC); age of onset; dementia; traumatic brain injury (TBI)
Authors: B L Plassman; R J Havlik; D C Steffens; M J Helms; T N Newman; D Drosdick; C Phillips; B A Gau; K A Welsh-Bohmer; J R Burke; J M Guralnik; J C Breitner Journal: Neurology Date: 2000-10-24 Impact factor: 9.910
Authors: Elizabeth H Corder; Estifanos Ghebremedhin; Miles G Taylor; Dietmar R Thal; Thomas G Ohm; Heiko Braak Journal: Ann N Y Acad Sci Date: 2004-06 Impact factor: 5.691
Authors: Joan Lindsay; Danielle Laurin; René Verreault; Réjean Hébert; Barbara Helliwell; Gerry B Hill; Ian McDowell Journal: Am J Epidemiol Date: 2002-09-01 Impact factor: 4.897
Authors: Gregory Scott; Anil F Ramlackhansingh; Paul Edison; Peter Hellyer; James Cole; Mattia Veronese; Rob Leech; Richard J Greenwood; Federico E Turkheimer; Steve M Gentleman; Rolf A Heckemann; Paul M Matthews; David J Brooks; David J Sharp Journal: Neurology Date: 2016-02-03 Impact factor: 9.910
Authors: Leslie Grasset; M Maria Glymour; Kristine Yaffe; Samuel L Swift; Kan Z Gianattasio; Melinda C Power; Adina Zeki Al Hazzouri Journal: Alzheimers Dement Date: 2020-04-22 Impact factor: 21.566
Authors: Deborah E Barnes; Amy L Byers; Raquel C Gardner; Karen H Seal; W John Boscardin; Kristine Yaffe Journal: JAMA Neurol Date: 2018-09-01 Impact factor: 18.302
Authors: Trung P Nguyen; Jeff Schaffert; Christian LoBue; Kyle B Womack; John Hart; C Munro Cullum Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: John Darrell Van Horn; Andrei Irimia; Carinna M Torgerson; Avnish Bhattrai; Zachary Jacokes; Paul M Vespa Journal: J Neurosci Res Date: 2017-05-20 Impact factor: 4.164
Authors: Jeff Schaffert; Christian LoBue; Charles L White; Hsueh-Sheng Chiang; Nyaz Didehbani; Laura Lacritz; Heidi Rossetti; Marisara Dieppa; John Hart; C Munro Cullum Journal: Neuropsychology Date: 2018-02-01 Impact factor: 3.295